- Home
- FLUX vs AKTX Comparison
FLUX vs AKTX Comparison
Compare FLUX & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- AKTX
- Stock Information
- Founded
- FLUX N/A
- AKTX N/A
- Country
- FLUX United States
- AKTX United States
- Employees
- FLUX N/A
- AKTX N/A
- Industry
- FLUX Industrial Machinery/Components
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- FLUX Miscellaneous
- AKTX Health Care
- Exchange
- FLUX Nasdaq
- AKTX Nasdaq
- Market Cap
- FLUX 26.9M
- AKTX 29.1M
- IPO Year
- FLUX N/A
- AKTX N/A
- Fundamental
- Price
- FLUX $1.54
- AKTX $1.28
- Analyst Decision
- FLUX Strong Buy
- AKTX
- Analyst Count
- FLUX 2
- AKTX 0
- Target Price
- FLUX $6.00
- AKTX N/A
- AVG Volume (30 Days)
- FLUX 51.8K
- AKTX 11.7K
- Earning Date
- FLUX 05-08-2025
- AKTX 05-15-2025
- Dividend Yield
- FLUX N/A
- AKTX N/A
- EPS Growth
- FLUX N/A
- AKTX N/A
- EPS
- FLUX N/A
- AKTX N/A
- Revenue
- FLUX $63,074,000.00
- AKTX N/A
- Revenue This Year
- FLUX $11.10
- AKTX N/A
- Revenue Next Year
- FLUX $12.66
- AKTX N/A
- P/E Ratio
- FLUX N/A
- AKTX N/A
- Revenue Growth
- FLUX N/A
- AKTX N/A
- 52 Week Low
- FLUX $1.15
- AKTX $0.85
- 52 Week High
- FLUX $4.75
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- FLUX 38.94
- AKTX 47.39
- Support Level
- FLUX $1.78
- AKTX $1.20
- Resistance Level
- FLUX $1.78
- AKTX $1.42
- Average True Range (ATR)
- FLUX 0.12
- AKTX 0.08
- MACD
- FLUX -0.04
- AKTX -0.00
- Stochastic Oscillator
- FLUX 7.35
- AKTX 36.99
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).